关注
Michael Ha
Michael Ha
在 dal.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus
RS Noyce, DG Bondre, MN Ha, LT Lin, G Sisson, MS Tsao, ...
PLoS pathogens 7 (8), e1002240, 2011
5662011
Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation
S Habbous, KP Chu, H Lau, M Schorr, M Belayneh, MN Ha, S Murray, ...
Cmaj 189 (32), E1030-E1040, 2017
772017
Mutations in the Fusion Protein of Measles Virus That Confer Resistance to the Membrane Fusion Inhibitors Carbobenzoxy-d-Phe-l-Phe-Gly and 4-Nitro-2 …
MN Ha, S Delpeut, RS Noyce, G Sisson, KM Black, LT Lin, D Bilimoria, ...
Journal of virology 91 (23), 10.1128/jvi. 01026-17, 2017
262017
Radiation dose enhancement using gold nanoparticles with a diamond linear accelerator target: a multiple cell type analysis
O Piccolo, JD Lincoln, N Melong, BC Orr, NR Fernandez, J Borsavage, ...
Scientific Reports 12 (1), 1559, 2022
242022
The zebrafish xenograft platform—A novel tool for modeling KSHV-associated diseases
ES Pringle, J Wertman, N Melong, AJ Coombs, AL Young, D O’Leary, ...
Viruses 12 (1), 12, 2019
142019
Diabetes in day case general and vascular surgery: A multicentre regional audit
E Fletcher, A Askari, Y Yang, S Adegbola, Y Al‐Obudi, D Bernstein, ...
International Journal of Clinical Practice 74 (4), e13472, 2020
22020
A different entity: a population based study of characteristics and recurrence patterns in oropharyngeal squamous cell carcinomas
S Murray, MN Ha, K Thompson, RD Hart, M Rajaraman, SL Snow
Journal of Otolaryngology-Head & Neck Surgery 44 (1), 30, 2015
22015
174 Implementation of Patient Reported Outcome (PRO) Measurements for Patients with Bone Metastases: A Single-Centre Narrative of Challenges and Future Directions
A Gupta, S Chisholm, M Nolan, N McMaster, J Kaal, R Urquhart, A Caissie, ...
Radiotherapy and Oncology 198, S73-S74, 2024
2024
112: An” Early Adopter” of CPQR’s Patient Reported Outcome (PRO) Initiative: Lessons Learned Through Implementation of an Electronic PRO Platform Across a Mulit-Center …
CA Davis, N McMaster, M Arab, T Ashford, S Chisholm, M Ha, ...
Radiotherapy and Oncology 174, S49, 2022
2022
86: Radiation Dose Enhancement Using Gold Nanoparticles with a Diamond Linear Accelerator Target: A Multiple Cell Type Analysis
O Piccolo, M Ha, J Robar, J Lincoln, N Melong, J Berman, N Fernandez, ...
Radiotherapy and Oncology 174, S38, 2022
2022
Virtually, Anything is Possible: Implementation of an Electronic Patient Reported Outcome Platform Across A Multi-Center Radiation Oncology Department
N McMaster, M Arab, T Ashford, S Chisholm, CA Davis, M Ha, R McKnight, ...
Journal of Medical Imaging and Radiation Sciences 53 (2), S4, 2022
2022
Low Z Target Beam Enhances Gold/Gadolinium Nanoparticle Mediated Cell Kill in Zebrafish Xenograft Model
MN Ha, O Piccolo, N Melong, J Lincoln, DDM Parsons, A Detappe, ...
International Journal of Radiation Oncology, Biology, Physics 105 (1), E677, 2019
2019
Zebrafish model to study the use of nanoparticles as a radiosensitizer in low Z target beams
M Ha, O Piccolo, N Melong, J Lincoln, D Parsons, A Detappe, O Tillement, ...
Radiotherapy & Oncology 133, S20-S21, 2019
2019
An in vivo model to study the use of nanoparticles as a radiosensitizer in radiation beams generated from a low Z target
MN Ha, O Piccolo, N Melong, D Parsons, A Detappe, O Tillement, ...
International Journal of Radiation Oncology, Biology, Physics 99 (2), E593-E594, 2017
2017
In Vitro and In Vivo Studies with Measles Virus and its Interaction with the Mouse Innate Immune System
MN Ha
University of Toronto (Canada), 2012
2012
系统目前无法执行此操作,请稍后再试。
文章 1–15